SEARCH

SEARCH BY CITATION

References

  • Abramoff M. D., Magelhaes P. J. and Ram S. J. (2004) Image Processing with ImageJ. Biophotonics Int. 11, 3642.
  • Ahn M., Kim S., Kang M., Ryu Y. and Kim T. D. (2006) Chaperone-like activities of alpha-synuclein: alpha-synuclein assists enzyme activities of esterases. Biochem. Biophys. Res. Commun. 346, 11421149.
  • Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W. and Lipman D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 33893402.
  • Altschul S. F., Wootton J. C., Gertz E. M., Agarwala R., Morgulis A., Schaffer A. A. and Yu Y. K. (2005) Protein database searches using compositionally adjusted substitution matrices. FEBS J. 272, 51015109.
  • Anderson J. P., Walker D. E., Goldstein J. M. et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 2973929752.
  • Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A. and Struhl K. (1990) Current Protocols in Molecular Biology. John Wiley Sons Inc, New York.
  • Bartels T., Choi J. G. and Selkoe D. J. (2011) alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107110.
  • Bensalem N., Masscheleyn S., Mozo J. et al. (2007) High sensitivity identification of membrane proteins by MALDI TOF-MASS spectrometry using polystyrene beads. J. Proteome Res. 6, 15951602.
  • Beyer K. (2006) Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers. Acta Neuropathol. 112, 237251.
  • Braak H., Del Tredici K., Rub U., de Vos R. A., Jansen Steur E. N. and Braak E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197211.
  • Broersen K., van den Brink D., Fraser G., Goedert M. and Davletov B. (2006) Alpha-synuclein adopts an alpha-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation. Biochemistry 45, 1561015616.
  • Castellani R., Smith M. A., Richey P. L. and Perry G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737, 195200.
  • Choi Y. G. and Lim S. (2010) Nε-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie 92, 13791386.
  • Cuatrecasas P., Fuchs S. and Anfinsen C. B. (1968) The tyrosyl residues at the active site of staphylococcal nuclease. Modifications by tetranitromethane. J. Biol. Chem. 243, 47874798.
  • Fauvet B., Mbefo M. K., Fares M. B. et al. (2012) Alpha-synuclein in the central nervous system and from erythrocytes, mammalian cells and E. coli exists predominantly as a disordered monomer. J. Biol. Chem. 287, 1534515364.
  • Freichel C., Neumann M., Ballard T. et al. (2007) Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice. Neurobiol. Aging 28, 14211435.
  • Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M. S., Shen J., Takio K. and Iwatsubo T. (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160164.
  • Gai W. P., Yuan H. X., Li X. Q., Power J. T., Blumbergs P. C. and Jensen P. H. (2000) In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166, 324333.
  • Ghiso J., Wisniewski T. and Frangione B. (1994) Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8, 4964.
  • Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290, 985989.
  • Gomes R. A., Sousa Silva M., Vicente Miranda H., Ferreira A. E., Cordeiro C. A. and Freire A. P. (2005) Protein glycation in Saccharomyces cerevisiae. Argpyrimidine formation and methylglyoxal catabolism. FEBS J. 272, 45214531.
  • Hasegawa M., Fujiwara H., Nonaka T., Wakabayashi K., Takahashi H., Lee V. M., Trojanowski J. Q., Mann D. and Iwatsubo T. (2002) Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem. 277, 4907149076.
  • Hirsch E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33(Suppl 1), 5259.
  • Iwatsubo T. (2003) Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease. J. Neurol. 250 (Suppl 3), III11III14.
  • Jakes R., Spillantini M. G. and Goedert M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett. 345, 2732.
  • Kahle P. J., Neumann M., Ozmen L. et al. (2000) Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J. Neurosci. 20, 63656373.
  • Kessler J. C., Rochet J. C. and Lansbury P. T. Jr (2003) The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry 42, 672678.
  • Kim T. D., Paik S. R., Yang C. H. and Kim J. (2000) Structural changes in alpha-synuclein affect its chaperone-like activity in vitro. Protein Sci. 9, 24892496.
  • Kim T. D., Paik S. R. and Yang C. H. (2002) Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 41, 1378213790.
  • Kim T. D., Choi E., Rhim H., Paik S. R. and Yang C. H. (2004) Alpha-synuclein has structural and functional similarities to small heat shock proteins. Biochem. Biophys. Res. Commun. 324, 13521359.
  • Klucken J., Outeiro T. F., Nguyen P., McLean P. J. and Hyman B. T. (2006) Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging. FASEB J. 20, 20502057.
  • Kruger R., Kuhn W., Muller T. et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106108.
  • Niedermeyer T. H. and Strohalm M. (2012) mMass as a software tool for the annotation of cyclic peptide tandem mass spectra. PLoS ONE 7, e44913.
  • Ohrfelt A., Zetterberg H., Andersson K. et al. (2011) Identification of novel alpha-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem. Res. 36, 20292042.
  • Oueslati A., Fournier M. and Lashuel H. A. (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog. Brain Res. 183, 115145.
  • Paleologou K. E., Schmid A. W., Rospigliosi C. C. et al. (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J. Biol. Chem. 283, 1689516905.
  • Park S. M., Jung H. Y., Chung K. C., Rhim H., Park J. H. and Kim J. (2002) Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability. Biochemistry 41, 41374146.
  • Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 20452047.
  • Przedborski S., Chen Q., Vila M. et al. (2001) Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637640.
  • Schell H., Hasegawa T., Neumann M. and Kahle P. J. (2009) Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience 160, 796804.
  • Shevchenko A., Wilm M., Vorm O. and Mann M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850858.
  • Strohalm M., Hassman M., Kosata B. and Kodicek M. (2008) mMass data miner: an open source alternative for mass spectrometric data analysis. Rapid Commun. Mass Spectrom. 22, 905908.
  • Strohalm M., Kavan D., Novak P., Volny M. and Havlicek V. (2010) mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data. Anal. Chem. 82, 46484651.
  • Uversky V. N., Yamin G., Munishkina L. A., Karymov M. A., Millett I. S., Doniach S., Lyubchenko Y. L. and Fink A. L. (2005) Effects of nitration on the structure and aggregation of alpha-synuclein. Brain Res. Mol. Brain Res. 134, 84102.
  • Wang W., Perovic I., Chittuluru J. et al. (2011) A soluble alpha-synuclein construct forms a dynamic tetramer. Proc. Natl Acad. Sci. USA 108, 1779717802.
  • Weinreb P. H., Zhen W., Poon A. W., Conway K. A. and Lansbury P. T. Jr (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35, 1370913715.
  • Zabrocki P., Bastiaens I., Delay C., Bammens T., Ghillebert R., Pellens K., De Virgilio C., Van Leuven F. and Winderickx J. (2008) Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson. Biochim. Biophys. Acta 1783, 17671780.
  • Zarranz J. J., Alegre J., Gomez-Esteban J. C. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164173.